Mutant RB69 DNA polymerase

US9593315B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9593315-B2
Application numberUS-201615200670-A
CountryUS
Kind codeB2
Filing dateJul 1, 2016
Priority dateJun 5, 2009
Publication dateMar 14, 2017
Grant dateMar 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.

First claim

Opening claim text (preview).

What is claimed: 1. An isolated nucleic acid comprising a nucleotide sequence encoding a mutant DNA polymerase having the amino acid sequence of SEQ ID NO:2. 2. A vector comprising the nucleic acid sequence of claim 1 . 3. The vector of claim 2 , further comprises a promoter sequence which is operably joined to the nucleic acid sequence encoding the mutant DNA polymerase. 4. The vector of claim 3 , wherein the promoter is constitutive or inducible. 5. A host cell carrying the vector of claim 2 . 6. A host cell carrying the vector of claim 3 . 7. A method for producing a mutant DNA polymerase polypeptide, comprising culturing the host cell of claim 6 under conditions suitable for the host cell to produce the mutant DNA polymerase polypeptide. 8. The mutant DNA polymerase produced by the method of claim 7 .

Assignees

Inventors

Classifications

  • for detection of mutation or polymorphism · CPC title

  • C12N9/1252Primary

    DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

  • involving nucleic acids · CPC title

  • Methods for sequencing · CPC title

  • DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9593315B2 cover?
Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.
Who is the assignee on this patent?
Life Technologies Corp
What technology area does this patent fall under?
Primary CPC classification C12N9/1252. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).